Moreover, CD84 knockdown substantially attenuated TOM20 (mitochondrial marker), MFN1 (mitochondrial fusion marker), and HMGB1 expression levels, which indicated mitochondrial dysfunction upon CD84 deletion in AML (Figure 7B). The gene discussed is CD84; the disease is acute myeloid leukemia.